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Most patients experience changes to prescribed medicines during a hospital stay. Ensuring 
they understand such changes is important for preventing adverse events post-discharge 
and optimising patient understanding. However, little work has explored the information 
that patients receive about medicines or their perceived needs for information and support 
after discharge. 
Aim 
To determine information that hospital in-patients who experience medicines changes 
receive about their medicines during admission and their needs and preferences for, and 
use of, post-discharge support. 
Methods 
Cross-sectional survey with adult medical in-patients experiencing medicines changes in six 
English hospitals, with telephone follow-up 2-3 weeks post-discharge. 
Results 
A total of 444 in-patients completed surveys and 99 of these were followed-up post-
discharge. Of the 444, 44 (10%) were unaware of changes to medicines and 65 (16%) did not 
recall discussing them with a health professional, but 305 (77%) reported understanding the 
changes. TǇƉĞŽĨŝŶĨŽƌŵĂƚŝŽŶƉƌŽǀŝĚĞĚĂŶĚƉĂƚŝĞŶƚƐ ?ƉĞƌĐĞŝǀĞĚŶĞĞĚĨŽƌƉŽƐƚ-discharge 
support differed between hospitals. Information about changes was most frequently 
provided by consultant medical staff (157; 39%) with pharmacists providing information 
least often (71; 17%). One-third of patients surveyed considered community pharmacists as 
potential sources of information about medicines and associated support post-discharge. 
Post-discharge, just 5% had spoken to a pharmacist, although 35% reported medicines-
related problems. 
Conclusion 
In North-West England, patient inclusion in treatment decisions could be improved, but 
provision of information prior to discharge is reasonable. There is scope to develop hospital 
and community pharmacists ? role in medicines optimisation to maximise safety and 
effectiveness of care.  




Patients ? medicines are often changed during a hospital stay, with over 90% of elderly 
medical patients experiencing a change to their prescribed medication during an in-patient 
stay (1) and medication discrepancies at discharge being associated with increased risk of 
re-admission (2). Leading on from this, medicines optimisation guidance issued by the UK  
National Institute for Health and Care Excellence (NICE) recommends that changes to 
medicines (including reasons) be communicated between treatment settings (3). Further, 
NICE guidance on medicines adherence (4) recommends that patients are involved in 
decisions about their medicines, including discussing why they may benefit and the 
treatment options, including the pros and cons. However, it is not clear how this guidance 
translates to practice at the point of discharge, when patients, or their carers, assume 
responsibility for managing their medicines. 
 
In 2015, 72% of patients surveyed in English hospitals reported they had received 
completely clear written or printed information about the medicines they were given to 
take home (5). However, other work found that only 44% of in-patients felt fully informed 
about their medicines (6). Concerns around defective post-discharge medicines 
reconciliation processes (7) led, in part, to recommendations for community pharmacy led  
Medicines Use Reviews (MURs) to be targeted at patients discharged from hospital with two 
or more medicines (8). These discharge MURs (dMUR), and the New Medicines Service 
(NMS) which is also provided across English community pharmacies (8), involve discussion 
between a community pharmacist and the patient regarding their medicines to promote 
understanding of their treatment and support medicines adherence (9,10). However, uptake 
of such services amongst discharged patients may be suboptimal (11).  
 
Previous studies have explored ƉĂƚŝĞŶƚƐ ?ŶĞĞĚƐ regarding information about medicines on 
discharge in relation to myocardial infarction (12) or post-surgical wounds (13) but few have 
investigated information provided to patients regarding changes to medicines during 
hospitalisation. A small study in one UK hospital found that patients were more satisfied 
with the information provided relating to the purpose and use of medicines than that about 
the potential problems that they may experience with their medicines (14). A New Zealand 
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study showed that although older people often experience medicine changes during 
hospitalisation, they were often unaware of the details (15). A qualitative study in the 
Netherlands found that patients wanted more detailed information, particularly regarding 
alternatives to prescribed medication and adverse effects (16), while an Australian survey 
found 37% wanted more time to talk about their medications during their hospital stay or 
post-discharge (17). 
 
This study aimed to determine information that hospital in-patients who experience 
medicines changes receive about their medicines during admission and their needs and 
preferences for, and use of, post-discharge support.  
METHOD 
This cross-sectional study involved two stages: (1) a face-to-face survey of adult medical in-
patients in a convenience sample of three teaching hospitals and three district general 
hospitals in Northwest England, followed by (2) a telephone survey approximately two 
weeks after discharge. Teacher-practitioner pharmacists working at the selected hospitals 
were approached to support running of the study within their organisation.  Data were 
collected between January 2015 and March 2015. In common with hospitals across the UK, 
all hospitals had a ward based pharmacy service, which includes pharmacist clinical input 
into patient care and pharmacist-patient interaction. 
 
Consent was obtained from the nurse in charge for each ward to allow data collection and 
in-patients were screened against the below criteria by a pharmacist or nurse from the ward 
team as part of discharge planning. Inclusion criteria were: in-patient on a participating 
ward; currently prescribed medicines, with a prescribing change made during the hospital 
stay (including initiation); ready for discharge from hospital; stable and well enough to 
participate (in the opinion of the nurse in charge); and able to communicate in English. 
Exclusion criteria were: aged under 18 years; cognitive impairment or confusion adversely 
affecting ability to communicate in the opinion of the screening healthcare professional; 
planned discharged to a nursing home or palliative care; or any other patient judged 
unsuitable by the nurse-in-charge.  
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Twelve final-year pharmacy students provided written study information to patients 
identified through screening and gave 30 minutes to decide on participation. Written 
consent was then taken from willing patients, who then self-completed a questionnaire, 
with students helping with this if necessary. Patients were then invited to participate in 
stage 2, with further written consent and contact details being taken from those who 
agreed. Prior to data collection, all students completed Good Clinical Practice training 
offered by the UK National Institute for Health Research. 
 
The Stage 2 telephone survey was carried out by an experienced research associate 
approximately two weeks after discharge with responses documented on a pro forma using 
written notes. 
 
The stage 1 questionnaire was developed by the research team, based on a previous study 
(6), and adapted using the NICE Audit tool for medicines adherence (18). Face validity was 
evaluated by the research team, drawing on expertise in provision of information about 
medicines and health psychology. Questionnaires comprised 52 questions on: demographics 
and medicines use; changes to, and information received about, medicines during hospital 
stay; use of, and preferences for, information about medicines; and anticipated needs and 
preferences for support post-discharge (copies of the questionnaire are available from the 
corresponding author). 
 
The stage 2 telephone survey comprised seven closed questions with follow-up questions to 
explore experiences more fully. The questions allowed structured information to be 
gathered in a short (five minutes) discussion, ŐŝǀŝŶŐƌĞŐĂƌĚƚŽƌĞƐƉŽŶĚĞŶƚƐ ?ƌĞĐĞŶƚĚŝƐĐŚĂƌŐĞ
from hospital. Questions covered: information and support needed since discharge; 
knowledge about medicines changed during admission; problems (including supply) with 
medicines since discharge; and interactions with health professionals since discharge. 
 
The methods and questions were piloted with 32 in-patients (13 of whom were followed up 
by telephone) in two NHS hospitals, which were not included in the main study, to assess 
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feasibility, estimate recruitment and refine the instruments. Minor amendments were made 
to the stage 1 questionnaire to reduce repetition and overall length.  
 
NHS research ethics committee approval (reference 13/WM/0420) and NHS Trust 
governance approvals were obtained for this study.  
 
Stage 1 data and responses to closed questions from stage 2 were collated and analysed in 
SPSS Version 22. Frequencies and descriptive statistics are reported, with percentages 
calculated from the total number of responses to individual questions. Chi-squared tests 
were used for differences between sub-groups anĚ^ƉĞĂƌŵĂŶ ?ƐĐŽƌƌĞůĂƚŝŽŶĐŽĞĨĨŝĐŝĞŶƚfor 
correlations between responses to questions. An a priori value of p<0.05 was set for 
significance. To protect confidentiality, hospitals have been allocated a code letter (A-F) 
where individual sites are listed in the results. 
Descriptions of post-discharge experiences from follow-up questions were independently 
coded by two researchers, against a basic framework , designed prior to data collection and 
exploring to key elements of information needs relating to medicines, derived from stage 1 
and prior work. Following initial independent coding, agreement on final coding was 
reached through discussion. 
RESULTS 
A total of 444 patients from the six hospitals completed the stage 1 survey, 171 (38.5%) of 
whom agreed to follow-up and 99 of these completed the stage 2 survey. Among stage 1 
respondents 233 (52.8%; missing=3) were female, 233 (53.1%; missing=5) were aged over 
65, and 387 (87.6%; missing=2) reported using prescribed medicines prior to admission 
(Table 1).  
Stage 1: Face-to-face survey 
Almost all respondents who reported using medicines prior to admission had a regular 
pharmacy (371/387; 95.6%) and 179 (n=387; 46.3%) reporting having discussed their 
medicines with a pharmacist in a community pharmacy consultation room, of whom 149 
(83%; n=179) indicated this related to their regular medicines.  
Although one or more medicines had been changed or initiated for all patients invited to 
join the study, only 400 (90.1%, n=444) participants reported being aware of changes, with 
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36 (8.1%) believing no change had been made and the remainder being unable to 
remember a change. Changes recalled were: new medicine started (331/400; 82.8%), 
existing medicine stopped (162/400; 40.5%); and changes to prescribed medicines 
(146/400; 36.5%). Almost two-fifths (156/405; 38.5%) reported feeling involved in decisions 
to make changes, 318/419 (75.9%) had received enough information about their medicines 
and 305/397 (76.8%) felt that they understood the changes to their medicines. There were 
no differences in these proportions with respect to age, sex or education of the patient or 
their previous use of medicines, but there was important variation between the six hospitals 
in the proportion: feeling involved in decisions; receiving enough information; and 
understanding the changes (Table 2). Across the hospitals, the proportions of patients 
reporting that they felt involved  in decisions correlated with the proportions of those who 
felt that they received enough information (U=0.829; p=0.042) and that they understood 
information received (U=0.886; p=0.019).  
Overall, 208 (51.2%) patients recalled discussing their medicines with individuals from one 
healthcare professional group during their hospital stay, but a further 133 (30.0%) discussed 
medicines with individuals from more than one group, whilst 65 (16.0%) did not recall 
discussing medicines with any health professional. Again, meaningful differences were 
found between hospitals (Table 2). Patients most frequently recalled discussing medicines 
with consultant medical staff (157; 38.7%), followed by non-consultant medical staff (155; 
34.9%), nurses (147; 33.1%), and pharmacists (71; 17.4%).  
Of those who recalled discussing medicine changes, the majority felt informed about the 
benefits and drawbacks of treatment (282; 72.3%), were encouraged to ask questions (245; 
62.8%) and were told how the medicine may help their condition (220; 59.1%), although 
only half (191; 49.6%) reported being asked what difference they hoped the medicine would 
make. Even where received, information was not always provided in the best possible way, 
with only 38.6% (149/386) recalling being offered information before a medicine was 
prescribed. Of these, 112/135 (83.0%) found information clear and easy to understand, 
108/134 (80.6%) reported their understanding having been checked, and 60.4% (81/134) 
reported that staff gave information on where to find additional information or help.   
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There was variation in the proportions of patients across hospitals reporting receiving 
information on what their medicines were for, side effects, how to obtain further supplies, 
and how to use them (Table 3).  
 
Most patients reported preferring to obtain information about medicines from health 
professionals, followed by patient information leaflets (PILs) supplied with medicines (Figure 
1). The most common source of information about medicines was the GP (342; 78.4%), 
followed by community pharmacists (129; 29.7%), consultants/hospital doctors (68; 15.7%) 
and practice/community nurses (48; 11.6%), with family or friends, the internet and media 
being little used as sources. A significantly higher proportion of respondents who had 
previously had a consultation with a pharmacist reported pharmacists as a likely source of 
information (76/179; 42.5%) compared to those who had not experienced a consultation 
(42/209; 20.1%), p<0.001. 
Expectations of support needed after discharge in a number of areas again varied across 
hospitals (Table 3). The perceived need for help/support was not related to age, gender, 
educational level or number of medicines taken pre-admission. Of those who did not 
receive enough information about their medicines during their hospital stay, 69.7% (69/99) 
considered they would need support regarding what their medicine was for and if it was 
working following discharge, compared to just 54.2% (167/308) of those who had received 
sufficient information (Chi-square; p=0.001). The desire for support with medicine-related 
worries was also higher in those who did not receive enough information (72/100; 72.0%) 
compared to those who did (162/309; 52%) (Chi-square; p<0.001). 
Stage 2: Post-discharge telephone survey 
Of the 171 patients whoe agreed to interview, 99 were successfully followed up within 3 
weeks of discharge (58% successful follow-up). Main reasons for failed follow up included 
not contactable, changed mind, and unwell/returned to hospital since discharge. Of those 
who were interviewed, 31 (31%) reported needing support with their medicines after 
discharge. The type of issues described included: not knowing which medicines to continue 
taking, how long to take newly prescribed medicines, dose queries, side effect queries and 
wanting more information in general, particularly with respect to newly prescribed 
medicines or significantly changed regimens. Two interviewees reported not receiving a PIL 
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with their medicines, one of whom wanted to look up potential side effects. Help with these 
issues was most frequently sought from GPs (14) or hospital staff (8).  
Over one-third (35%) of interviewees described specific problems with medicines since 
discharge, the majority of these (22; 63%) were adverse effects, but others included lack of 
efficacy, difficulty maintaining the new routine and confusion about which medicines to 
take or how long to take them.  
While most respondents (59; 59%) had spoken to someone about their medicines since 
discharge, experiences differed considerably and, although the majority (82; 83%) said they 
knew enough about their medicines, it was apparent from some interviews that this may be 
inaccurate (Table 4).  
Only five (5%) of those interviewed recalled having a conversation with a community 
pharmacist since discharge, only two (2%) of which appeared to be formal consultations. 
DISCUSSION 
In our study, many patients did not feel involved in prescribing decisions made during their 
hospital stay, with two-fifths reporting information being offered before medicines were 
prescribed and a significant minority not recalling ever discussing medicines with any health 
professional. Indeed, some were not even aware of changes having been made. There was 
variation between hospitals in the numbers of health professional groups with whom 
patients recalled discussing medicines, the information provided and feeling of involvement 
in prescribing decisions. Patients who felt that information was insufficient were more likely 
to report needing post-discharge support. 
The present study is the first to our knowledge to cover pre- and post-discharge, collecting 
detailed information at the time of discharge to minimise recall bias and using questions 
aligned to NICE audit criteria to maximise relevance. Also, the post-discharge telephone 
survey was conducted within three weeks of discharge to minimise bias. The study data are 
patient self-reports and may not fully reflect true practice. However, these reports reflected 
the extent to which patients felt supported and this is important for concordance and 
adherence in medicines prescribing and use. The number of patients screened or 
approached to participate in the survey was not documented and response rates are not 
available. The proportion followed-up by telephone was just over half of those who 
consented to participate, representing 22% of the total participants, but they were 
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distributed across the hospitals and are broadly similar in demographic characteristics to the 
stage 1 study sample.  
The variation observed between hospital sites in terms of both involvement in decisions 
about care and receipt of information about medicines points to different approaches to 
this element of care in different organisations. NICE guidance relating to medicines 
adherence (4), which addresses many of these points, was published around the time of 
data collection, so it is likely that practice has developed in this respect over the past few 
years. However, successful initiation of medicines, promoting maximal patient adherence, is 
important to effective treatment and prevention of disease. Therefore, further work is 
needed to examine this variation in more detail and consider the implications in terms of 
patient outcomes.  
While almost all patients used a regular community pharmacy and many had previously 
experienced a consultation with a pharmacist about their medicines, only one in ten 
considered the community pharmacists as a source of information and support regarding 
medicines post-discharge. This was confirmed in the post-discharge interviews, where just 
2% of interviewees reported that they had discussed their medicines with a pharmacist in a 
private area. Many participants had a problem with one or more medicines post-discharge, 
mostly relating to adverse drug effects, where it is important for the patient to be well-
informed such that they are equipped to appropriately handle the situation.  
Previous work in other countries has identified the need and desire for more information to 
be provided to patients prior to discharge, particularly when medicines have been changed, 
to prevent problems occurring (15 W17). Medicines reconciliation during transfer of care, 
information provision during hospital stays, post-discharge contact or community pharmacy 
post-discharge medicines reconciliation have all been explored as mechanisms for reducing 
problems with medicines after discharge (19 W22). One USA study reported an average 3.85 
medicines discrepancies following discharge and emphasised the possible role of 
community pharmacists in supporting patients post-discharge (23). However, other work 
suggests that US community pharmacists do not routinely or consistently follow-up patients 
after discharge (24).   
Our findings contrast with the Adult In-patient Survey (AIS) (5), in that only 39% felt involved 
in decisions about medicines versus 59% in the AIS. This may be as a result of the different 
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wording used in the two studies  W in the present work, patients were asked if they were 
 “involved in the decisions to change their medicines ? ?ǁŚŝůƐƚŝŶƚŚĞAIS, they were asked 
ǁŚĞƚŚĞƌƚŚĞǇǁĞƌĞ “involved as much as they wanted to be in decisions about their care 
ĂŶĚƚƌĞĂƚŵĞŶƚ ?  W suggesting that a large proportion of these patients may not wish to be 
involved in decisions about their care. However, our findings are broadly comparable with 
the AIS in regard to the information that patients received about their medicines. The 
differences may arise from the emphasis in the present study on patients with medicines 
changes during hospital stays and the detailed level of questioning, which contrasts with the 
comprehensive inclusion criteria and general questions used in the AIS. 
Although over half the patients discussed changes with individuals from more than one 
professional group, around one in six did not recall discussing medicines with any healthcare 
professional - this was comparable with a previous survey (20%), involving many of the 
same hospitals (6).  
Although pharmacists are viewed by some health professionals as primary providers of 
information to patients about medicines (28), they were cited least frequently as having 
discussed medicines with patients. Although it is possible that a pharmacist had spoken to 
many of these patients, but had not been recognised as such, it is possible that patients 
chose to talk to doctors about all aspects of their care.  
In 2012, the Royal Pharmaceutical Society launched guidance to improve transfer of 
information between primary and secondary care (25) and there have been several 
attempts to increase uptake of dMURs (26), with mixed result (11,27,29). However, 
anecdotally, there is a perception that patients remain unaware of this service and the 
potential benefit it, and NMS, could offer. Although the low uptake seen in the present 
study appears to confirm this, around one third of patients did recognise pharmacists as a 
useful source of information, showing a possible change in patient knowledge. Post-
discharge services are however still some way off meeting the NICE standards regarding 
medicines optimisation (3), so information provided during hospital stays remains a key 
mechanism to ensuring patient understanding of medicines changes.  
CONCLUSION 
The degree to which adult hospital in-patients involved in this study felt involved in 
decisions about their care was suboptimal and did not align with prevailing guidance. Four in 
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five patients were satisfied with information provided about medicines at the point of 
discharge but patient use of follow-up support post-discharge such as dMURs and NMS was 
limited and an opportunity to identify and resolve issues relating to medicines may be being 
missed. There was variation between hospitals in the way in which information about 
medicines was provided to patients, including the staff providing such information and 
further work is needed to explore this. Pharmacists appear to have had a limited role both in 
hospital and community settings and there is considerable scope for development of their 
role in supporting patients around care transition.  
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Table 1 Demographic details (missing data for each item excluded from analysis) 
Characteristic Stage 1 (n=444)  Stage 2 (n=99) 
Sex 
Female 233 (52.8%) 42 (45%) 
Male 208 (46.8%) 47 (47%) 
Age group 
40 and under 40 (9.1%) 14 (15%) 
41  W 65 166 (37.8%) 43 (46%) 
66  W 75 99 (22.6%) 22 (24%) 
76 or over 134 (30.5%) 14 (15%) 
Educational level 
None/primary 65 (14.9%) 10 (11%) 
Secondary 211 (48.5%) 33 (36%) 
College/further education 98 (22.5%) 29 (32%) 
Higher education 61 (14.0%) 19 (21%) 
Ethnicity White 421 (95.9%) 88 (96%) 
Work status 
Full or part-time employed 101 (23.3%) 31 (34%) 
Retired 253 (58.3%) 40 (44%) 




Any medicines 387 (87.6%) 85 (90%) 
4 or fewer 134 (34.8%) 36 (38%) 
5 to 7 112 (29.1%) 21 (22%) 
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Table 2 Differences in patient experiences between hospitals 
Hospital 













Discussed medicines with health 
professional groups 
One only More than one 
A (n=93) 31 (36%) 74 (81%) 66 (73%) 34 (40%) 44 (51%) 
B (n=100) 34 (40%) 70 (73%) 67 (86%) 47 (58%) 24 (30%) 
C (n=70) 16 (23%) 43 (61%) 47 (67%) 28 (41%) 30 (43%) 
D (n=52) 13 (30%) 33 (66%) 23 (59%) 21 (43%) 3 (6%) 
E (n=61) 28 (50%) 39 (68%) 40 (76%) 30 (53%) 17 (30%) 
F (n=68) 34 (53%) 59 (88%) 62 (94%) 48 (75%) 15 (23%) 
Overall 
(n=444) 
156 (39%) 318 (76%) 305 (77%) 208 (51%) 133 (31%) 
P value (Chi 
Square test) 
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Table 3 Expectations for support required after discharge 
Hospital 
Number (% of those responding to the question) of patients who anticipated needing 
help post-ĚŝƐĐŚĂƌŐĞǁŝƚŚ ? 
What 
medicine is 
for and how 



















A (n=93) 44 (47%) 41 (46%) 33 (37%) 31 (35%) 30 (34%) 25 (29%) 
B (n=100) 53 (59%) 51 (57%) 46 (51%) 44 (48%) 55 (61%) 33 (37%) 
C (n=70) 45 (64%) 42 (60%) 32 (46%) 33 (48%) 27 (39%) 16 (23%) 
D (n=52) 30 (58%) 30 (58%) 9 (18%) 7 (15%) 6 (12%) 7 (14%) 
E (n=61) 30 (50%) 35 (58%) 25 (42%) 31 (52%) 19 (32%) 23 (39%) 
F (n=68) 47 (69%) 44 (65%) 41 (60%) 37 (54%) 21 (31%) 16 (24%) 
Overall 
(n=444) 
247 (57.7%) 243 (56.8%) 186 (43.3%) 183 (43.1%) 158 (37.0%) 120 (28.2%) 
p-value*  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Differences between hospital trusts: *Chi-square test 
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Table 4 post-discharge interview findings  
Type of 
experience 




Had GP appointment to review changes  W agreed to continue 
medicines as prescribed in hospital. Good chat over 
everything, any questions answered. 
Female, 40 or under 
Pharmacist visited ward regularly in hospital, so knew 
enough about medicines. Cardiac nurse visits to review 
weekly. She's very good - can ask any questions and 
concerns. 
Female, 76-85 
You can never know enough, but what they explained was 
enough. Saw pharmacist when went to collect medicines and 
was taken to one side and told about strength of medicine 
(morphine), expected side effects.  Pharmacist asked if he 
wanted to go into private room but was OK to talk in public. 
GP re-iterated these, checked through questions and told 




Changed antidepressant and wanted to know more about it. 
Tried to speak to GP but got put through to the practice 
nurse - but she wasn't able to answer queries. GP never rang 
back. 
Female, 41-65 
had quick review with GP, is continuing medicines as 
prescribed in hospital - ǁĂƐƐŚŽƌƚĂƉƉŽŝŶƚŵĞŶƚƐŽĚŝĚŶ ?ƚĨĞĞů
she had chance to discuss questions/concerns. 
Female, 66-75 
Medicines are delivered from pharmacy, assumed they had 
the report from the GP, but was missing 5 of the 6 tablets 
prescribed while in hospital. Had GP check-up last Thursday, 
changed some of the medicines had from hospital (on 15 so 
unsure which ones). Patient asked questions but still 
confused, although reassured doing okay. 
Female, 86 or over 
Actual or potential 
adverse events 
ƐĂǁůŽĐƵŵ'WǁŚŽǁĂƐŶ ?ƚĨĂŵŝůŝĂƌǁŝƚŚƉĂƚŝĞŶƚƐ ?ŵĞĚŝĐĂů
history - left medicine it is, but patient stopped taking 
(because of a suspected adverse reaction experienced  W 
hives, itch). 
Male, 41-65 
Felt knew enough about medicines, but was taking a 
ŵĞĚŝĐŝŶĞĚĂŝůǇĨŽƌǁŚŝĐŚŝŶĨŽƌŵĂƚŝŽŶƐƚĂƚĞĚ P “ŽŶĞƚŽďĞ
ƚĂŬĞŶǁĞĞŬůǇŽƌĂƐĂĚǀŝƐĞĚďǇǇŽƵƌŚĞĂůƚŚƉƌŽĨĞƐƐŝŽŶĂů ?ĂŶĚ
he was also unsure for how long the medicine would be 
needed. Not attempted to see GP as had sufficient medicines 
supply. 
Male, 66-75 
Felt had no information at all about change. Saw GP who 
took blood pressure and wasn't happy and reversed the dose 
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